Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology

Cites (299)

Items 201–298 of 298

1. Adenosine A2A receptor antagonism reverses the effects of dopamine receptor antagonism on instrumental output and effort-related choice in the rat: implications for studies of psychomotor slowing
   Andrew M. Farrar, Mariana Pereira, FRANCISCO FIERRO VELASCO, Jörg Hockemeyer, Christa Elisabeth Müller, John D. Salamone · 2006 · Psychopharmacology
2. The role of dopamine D1 receptor transmission in effort-related choice behavior: Effects of D1 agonists
   Samantha E. Yohn, Jessica L. Santerre, Eric J. Nunes, Rouba Kozak, Samantha J. Podurgiel, Mercè Correa, John D. Salamone · 2015 · Pharmacology Biochemistry and Behavior
3. Low Dopamine D2 Receptor Increases Vulnerability to Obesity Via Reduced Physical Activity, Not Increased Appetitive Motivation
   Jeff A. Beeler, Rudolf P. Faust, Susie Turkson, Honggang Ye, Xiaoxi Zhuang · 2015 · Biological Psychiatry
4. Psychopathological Correlates of Reduced Dopamine Receptor Sensitivity in Depression, Schizophrenia, and Opiate and Alcohol Dependence12
   K. Schmidt, B. Nolte-Zenker, J. Patzer, M. Bauer, L. G. Schmidt, Andreas Heinz · 2001 · Pharmacopsychiatry
5. The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion
   Samantha E. Yohn, Christian Thompson, Patrick A. Randall, Christie A. Lee, Christa Elisabeth Müller, Younis Baqi, Mercè Correa, John D. Salamone · 2014 · Psychopharmacology
6. The effect of 6-OHDA lesions of the nucleus accumbens septum on schedule-induced drinking, wheelrunning and corticosterone levels in the rat
   Wallace, M., Singer, G., Finlay, J., Gibson, S. · 1983 · Pharmacology Biochemistry and Behavior
7. Identification and treatment of symptoms associated with inflammation in medically ill patients
   Robert Dantzer, Lucile Capuron, Michael R. Irwin, Andrew H. Miller, Hélène Ollat, Victor Hugh Perry, Sarah Rousey, Raz Yirmiya · 2007 · Psychoneuroendocrinology
8. Different effects of haloperidol and extinction on instrumental behaviours
   John D. Salamone · 1986 · Psychopharmacology
9. The role of nucleus accumbens dopamine in responding on a continuous reinforcement operant schedule: A neurochemical and behavioral study
   Louise D. McCullough, Michael S. Cousins, John D. Salamone · 1993 · Pharmacology Biochemistry and Behavior
10. Dissociation of the role of nucleus accumbens dopamine in responding to reward-predictive cues and waiting for reward
    Ken T. Wakabayashi, Howard L. Fields, Saleem M. Nicola · 2004 · Behavioural Brain Research
11. Measuring reinforcement learning and motivation constructs in experimental animals: Relevance to the negative symptoms of schizophrenia
    Athina Markou, John D. Salamone, Timothy J. Bussey, Adam C. Mar, Daniela Brunner, Gary Gilmour, Peter D. Balsam · 2013 · Neuroscience & Biobehavioral Reviews
12. Involvement of Adenosine A2A Receptors in Depression and Anxiety
    Koji Yamada, Minoru Kobayashi, Tomoyuki Kanda · 2014 · International review of neurobiology
13. Toward a generalizable model of symptoms in major depressive disorder
    Christina M. Gullion, Augustus John Rush · 1998 · Biological Psychiatry
14. Demanding pups improve maternal behavioral impairments in sensitized and haloperidol-treated lactating female rats
    Mariana Pereira, Annabel Ferreira · 2006 · Behavioural Brain Research
15. Differential effects of selective adenosine antagonists on the effort-related impairments induced by dopamine D1 and D2 antagonism
    Eric J. Nunes, Patrick A. Randall, Jessica L. Santerre, Allison M. Given, Thomas N. Sager, Mercè Correa, John D. Salamone · 2010 · Neuroscience
16. Tetrabenazine is neuroprotective in Huntington's disease mice
    Hongyu Wang, Xi Chen, Yuemei Li, Tie-Shan Tang, Безпрозванный Илья Борисович · 2010 · Molecular Neurodegeneration
17. Adults with autism spectrum disorders exhibit decreased sensitivity to reward parameters when making effort-based decisions
    Cara R. Damiano, Joseph M. Aloi, Michael Tilghman Treadway, James W. Bodfish, Gabriel S. Dichter · 2012 · Journal of Neurodevelopmental Disorders
18. Antidepressant-like activity of the adenosine A2A receptor antagonist, istradefylline (KW-6002), in the forced swim test and the tail suspension test in rodents
    Koji Yamada, Minoru Kobayashi, Akihisa Mori, Peter G. Jenner, Tomoyuki Kanda · 2013 · Pharmacology Biochemistry and Behavior
19. Dopaminergic hypothesis for retarded depression: a symptom profile for predicting therapeutical responses
    Liborio Rampello, Giovanni Federico Nicoletti, R Raffaele · 1991 · Acta Psychiatrica Scandinavica
20. Pharmacologic Rescue of Motivational Deficit in an Animal Model of the Negative Symptoms of Schizophrenia
    Eleanor H. Simpson, Christoph Kellendonk, Ryan D. Ward, Vanessa L. Richards, Olga Lipatova, S. Fairhurst, Eric R. Kandel, Peter D. Balsam · 2011 · Biological Psychiatry
21. The Actions of Neuroleptic Drugs on Appetitive Instrumental Behaviors
    John D. Salamone · 1987 · Springer eBooks
22. Not All Antidepressants Are Created Equal: Differential Effects of Monoamine Uptake Inhibitors on Effort-Related Choice Behavior
    Samantha E. Yohn, Samantha L Collins, Hector M Contreras-Mora, Emily L. Errante, Margaret A. Rowland, Mercè Correa, John D. Salamone · 2015 · Neuropsychopharmacology
23. Neurobiological basis of motivational deficits in psychopathology
    John D. Salamone, Ivan G. Koychev, Mercè Correa, Philip K. McGuire · 2014 · European Neuropsychopharmacology
24. The dopamine reuptake inhibitor MRZ-9547 increases progressive ratio responding in rats
    Susanne Sommer, Wojciech Danysz, Hermann Russ, Barbara Valastro, Gunnar Flik, Wolfgang Hauber · 2014 · The International Journal of Neuropsychopharmacology
25. Optimal foraging: theory and experiment
    John Richard Krebs · 1977 · Nature
26. Neural substrates underlying effort computation in schizophrenia
    Gagan Fervaha, George Foussias, Ofer Agid, Gary J. Remington · 2013 · Neuroscience & Biobehavioral Reviews
27. The adenosine A2A antagonist MSX-3 reverses the effort-related effects of dopamine blockade: differential interaction with D1 and D2 family antagonists
    Lila T. Worden, Mona Shahriari, Andrew M. Farrar, Kelly S. Sink, Jörg Hockemeyer, Christa Elisabeth Müller, John D. Salamone · 2008 · Psychopharmacology
28. Reducing Ventral Tegmental Dopamine D2 Receptor Expression Selectively Boosts Incentive Motivation
    Johannes W. de Jong, Theresia J. M. Roelofs, Frédérique Mol, Anne E.J. Hillen, Katharina E. Meijboom, Mieneke C. M. Luijendijk, Harrie A M van der Eerden, Keith M. Garner, Louk J. M. J. Vanderschuren, Roger A.H. Adan · 2015 · Neuropsychopharmacology
29. Resolution of sleepiness and fatigue: A comparison of bupropion and selective serotonin reuptake inhibitors in subjects with major depressive disorder achieving remission at doses approved in the European Union
    James A. Cooper, Vivian L. Tucker, George I. Papakostas · 2013 · Journal of Psychopharmacology
30. Fatigue as a residual symptom of depression.
    Steven D. Targum, Maurizio Fava M. D · 2011 · PubMed Central
31. Fatigue in primary Sjögren’s syndrome – A link to sickness behaviour in animals?
    Erna Harboe, Anne Bolette Tjensvoll, Hege K. Vefring, Lasse G. Gøransson, Jan Terje Kvaløy, Roald Omdal · 2009 · Brain Behavior and Immunity
32. BEHAVIORAL ECONOMICS
    Warren Kurt Bickel, Leonard Green, Rudy E. Vuchinich · 1995 · Journal of the Experimental Analysis of Behavior
33. The effects of nucleus accumbens dopamine depletions on continuously reinforced operant responding: Contrasts with the effects of extinction
    John D. Salamone · 1995 · Pharmacology Biochemistry and Behavior
34. Effects of lisdexamfetamine and s-citalopram, alone and in combination, on effort-related choice behavior in the rat
    Samantha E. Yohn, Laura López‐Cruz, Peter H. Hutson, Mercè Correa, John D. Salamone · 2015 · Psychopharmacology
35. Fatigue as a core symptom in major depressive disorder: overview and the role of bupropion
    Chi‐Un Pae, Hyun Kook Lim, Changsu Han, Ashwin A. Patkar, David C. Steffens, Prakash S. Masand, Chul Lee · 2007 · Expert Review of Neurotherapeutics
36. Psychomotor retardation is a scar of past depressive episodes, revealed by simple cognitive tests
    Philip A. P. M. Gorwood, Stéphane Richard‐Devantoy, François Bayle, Marie-Laure Cléry-Melin · 2014 · European Neuropsychopharmacology
37. Clinical management of negative symptoms of schizophrenia: An update
    Eva-Maria Tsapakis, Trisevgeni Dimopoulou, Frank I. Tarazi · 2015 · Pharmacology & Therapeutics
38. Major depression during interferon-α treatment: vulnerability and prevention
    Francis E. Lotrich · 2009 · Dialogues in Clinical Neuroscience
39. The citalopram challenge test in patients with major depression and in healthy controls
    Thomas Kapitany, Monika Schindl, Shird Dieter Schindler, Barbara Heßelmann, Thomas Füreder, Christian Barnas, Werner Sieghart, Siegfried F. Kasper · 1999 · Psychiatry Research
40. Dopamine receptors in the ventral tegmental area affect motor, but not motivational or reflexive, components of copulation in male rats
    Elaine M. Hull, M.S. Weber, R.C. Eaton, Ronika Dua, Vincent P. Markowski, Lucille A. Lumley, Jason Moses · 1991 · Brain Research
41. Neuroanatomical and neurochemical basis of parenting: Dynamic coordination of motivational, affective and cognitive processes
    Mariana Pereira, Annabel Ferreira · 2015 · Hormones and Behavior
42. Is impact of fatigue an independent factor associated with physical activity in patients with idiopathic Parkinson's disease?
    Roy G. Elbers, Erwin E. H. van Wegen, Lynn Rochester, Victoria Hetherington, Alice Nieuwboer, Anne‐Marie Willems, Diana E. Jones, Gert Kwakkel · 2009 · Movement Disorders
43. Selection of sucrose concentration depends on the effort required to obtain it: studies using tetrabenazine, D1, D2, and D3 receptor antagonists
    Marta Pardo, Laura López‐Cruz, Noemí San Miguel, John D. Salamone, Mercè Correa · 2015 · Psychopharmacology
44. Motivated to do well: An examination of the relationships between motivation, effort, and cognitive performance in schizophrenia
    George Foussias, Ishraq Siddiqui, Gagan Fervaha, Steve W. Mann, Krysta McDonald, Ofer Agid, Konstantine K. Zakzanis, Gary J. Remington · 2015 · Schizophrenia Research
45. Balancing reward and work: anticipatory brain activation in NAcc and VTA predict effort differentially
    Kroemer, Nils B., Guevara, Alvaro, Ciocanea Teodorescu, Iuliana, Wuttig, Franziska, Kobiella, Andrea, Smolka, Michael N. · 2014 · NeuroImage
46. Neo-striatal rCBF correlates of psychomotor slowing in patients with major depression
    Ian Bernard Hickie, Philip B. Ward, Elizabeth M. Scott, Walter Haindl, Brenda Walker, Jennifer Dixon, Keelin Turner · 1999 · Psychiatry Research Neuroimaging
47. Dopamine/adenosine interactions involved in effort-related aspects of food motivation
    John D. Salamone, Mercè Correa · 2009 · Appetite
48. Longitudinal changes of day-time and night-time gross motor activity in clinical responders and non-responders of major depression
    Doron Todder, Serdal Caliskan, Bernhard Theodor Baune · 2009 · The World Journal of Biological Psychiatry
49. The role of nucleus accumbens dopamine in outcome encoding in instrumental and Pavlovian conditioning
    Lex, Bjoern, Hauber, Wolfgang · 2010 · Neurobiology of Learning and Memory
50. Depressive symptoms and taste reactivity in humans
    Anna Ścińska, Halina Sienkiewicz‐Jarosz, Wlodzimierz Kuran, Danuta Ryglewicz, Artur Rogowski, Elzbieta Wrobel, Agnieszka Korkosz, Andrzej Kukwa, Wojciech Kostowski, Przemysław Bieńkowski · 2004 · Physiology & Behavior
51. Aberrant reward processing in Parkinson's disease is associated with dopamine cell loss
    Esther Aarts, Rick C. G. Helmich, Marcel J. R. Janssen, Wim J.G. Oyen, Bastiaan R. Bloem, Roshan Cools · 2011 · NeuroImage
52. The relationship between change in apathy and changes in cognition and functional outcomes in currently non-depressed SSRI-treated patients with major depressive disorder
    Rothschild, Anthony J., Raskin, Joel, Wang, Chia-Ning, Marangell, Lauren B., Fava, Maurizio · 2014 · Comprehensive Psychiatry
53. Reversal of SSRI-Associated Apathy Syndrome by Discontinuation of Therapy
    Prasad R. Padala, Kalpana P. Padala, Varun Monga, Daniel Alberto Tipiana Ramírez, Dennis H. Sullivan · 2012 · Annals of Pharmacotherapy
54. Psychopharmacology of the negative symptoms: Current status and prospects for progress
    Michael C. Davis, William P. Horan, Stephen R. Marder · 2013 · European Neuropsychopharmacology
55. Effects of haloperidol on the biophysical characteristics of operant responding: Implications for motor and reinforcement processes
    Stephen C. Fowler, Mary M. LaCerra, Aaron Ettenberg · 1986 · Pharmacology Biochemistry and Behavior
56. The Double‐Edged Sword of Goal Engagement: Consequences of Goal Pursuit in Bipolar Disorder
    Sheri Lynn Johnson, Daniel Fulford, Charles S. Carver · 2012 · Clinical Psychology & Psychotherapy
57. Effort-based decision making as an objective paradigm for the assessment of motivational deficits in schizophrenia
    Gagan Fervaha, Mark Duncan, George Foussias, Ofer Agid, Guy Faulkner, Gary J. Remington · 2015 · Schizophrenia Research
58. Asymmetric dopamine loss differentially affects effort to maximize gain or minimize loss
    Omer Porat, Sharon Hassin‐Baer, Oren S. Cohen, Andrey Markus, Rachel Tomer · 2013 · Cortex
59. Dopamine-associated cached values are not sufficient as the basis for action selection
    Nick G. Hollon, Monica M. Arnold, Jerylin O. Gan, Mark E. Walton, Paul E. M. Phillips · 2014 · Proceedings of the National Academy of Sciences
60. Anxiolytic profile of ropinirole in the rat, mouse and common marmoset
    Derek C. Rogers, B. Costall, Annette M Domeney, Philip A. Gerrard, M. Greener, Maureen E Kelly, Jim J. Hagan, A. Jacqueline Hunter · 2000 · Psychopharmacology
61. Use of operant response duration to distinguish the effects of haloperidol from nonreward
    William O. Faustman, Stephen C. Fowler · 1981 · Pharmacology Biochemistry and Behavior
62. Anhedonia in Unipolar Major Depressive Disorder: A Review~!2009-10-26~!2010-02-18~!2010-04-08~!
    Gabriel S. Dichter · 2010 · The Open Psychiatry Journal
63. The novel adenosine A2A antagonist prodrug MSX-4 is effective in animal models related to motivational and motor functions
    Jessica L. Santerre, Eric J. Nunes, Rotem Kovner, Chelsea E. Leser, Patrick A. Randall, Lyndsey E. Collins‐Praino, Laura López‐Cruz, Mercè Correa, Younis Baqi, Christa Elisabeth Müller et al. · 2012 · Pharmacology Biochemistry and Behavior
64. A multicenter evaluation of bupropion versus placebo in hospitalized depressed patients.
    Fabre Lf, H. Keith H. Brodie, D. Garver, Zung Ww · 1983 · PubMed
65. Methylphenidate
    David Devos, Caroline Moreau, Arnaud Delval, Kathy Dujardin, Luc Defebvre, Régis Bordet · 2012 · CNS Drugs
66. Preladenant, a novel adenosine A(2A) receptor antagonist for the potential treatment of parkinsonism and other disorders.
    John D. Salamone · 2010 · PubMed
67. Motivational Deficits and Negative Symptoms in Schizophrenia: Concepts and Assessments
    L. Felice Reddy, William P. Horan, Michael Foster Green · 2015 · Current topics in behavioral neurosciences
68. Psychostimulants in the therapy of treatment-resistant depression: review of the literature and findings from a retrospective study in 65 depressed patients
    Stotz, Gabriele, Woggon, Brigitte, Angst, Jules · 1999 · Dialogues in Clinical Neuroscience
69. Linking the cytokine and neurocircuitry hypotheses of depression: A translational framework for discovery and development of novel anti-depressants
    Timothy M. Piser · 2010 · Brain Behavior and Immunity
70. Biochemical and anatomical substrates of depression and sickness behavior.
    Thomas C. Hanff, Stephanie J Furst, Thomas R. Minor · 2010 · PubMed
71. Quantifying Reinforcement Value and Demand for Psychoactive Substances in Humans
    Adrienne J. Heinz, Todd C. Lilje, Jon D. Kassel, Harriet de Wit · 2012 · Current Drug Abuse Reviews
72. Role of dopamine–adenosine interactions in the brain circuitry regulating effort-related decision making: insights into pathological aspects of motivation
    John D. Salamone, Mercè Correa, Andrew M. Farrar, Eric J. Nunes, Lyndsey E. Collins · 2010 · Future Neurology
73. Schedule-dependent effects of haloperidol and amphetamine: multiple-schedule task shows within-subject effects
    William F. Caul, Nicholas A. Brindle · 2001 · Pharmacology Biochemistry and Behavior
74. Anhedonia in Unipolar Major Depressive Disorder: A Review
    Gabriel S. Dichter · 2010 · The Open Psychiatry Journal
75. ¿Factores inmunes o depresión? La fatiga relacionada con la enfermedad de Parkinson
    Zoe Katsarou, Sevasti Bostantjopoulou, Olga Hatzizisi, Evangelia Giza, Ana Soler Cardona, George Kyriazis · 2007 · Revista de Neurología
76. Acquisition of schedule-induced polydipsia by rats in proximity to upcoming food delivery
    Ginesa Ana López Crespo, Miguel Rodríguez, Ricardo Pellón, Pilar Flores · 2004 · Learning & Behavior
77. Low doses of cis-flupentixol attenuate motor performance
    Gene M. Heyman, Michael M. Monaghan, Donald E. Clody · 1987 · Psychopharmacology
78. An economic approach to animal models of alcoholism.
    Gene M. Heyman · 2000 · PubMed
79. The Role of the Nucleus Accumbens Shell in the Mediation of the Reinforcing Properties of a Safety Signal in Free-Operant Avoidance: Dopamine-Dependent Inhibitory Effects of d-amphetamine
    Anushka B. P. Fernando, Gonzalo Pablo Urcelay, Adam C. Mar, Tony A Dickinson, Trevor William Robbins · 2013 · Neuropsychopharmacology
80. TJS-010, a new prescription of oriental medicine, antagonizes tetrabenazine-induced supression of spontaneous locomotor activity in rats
    Andi J. Tanra, Ariyuki Kagaya, Yasumasa Okamoto, Mitsutaro Mura Oka, Nobutaka Motohashi, Shigeto Yamawaki · 1995 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
81. Increased monoaminergic neurotransmission improves compliance with physical activity recommendations in depressed patients with fatigue
    Emelie Stenman, Åsa Lilja · 2012 · Medical Hypotheses
82. Partial inactivation of nucleus accumbens core decreases delay discounting in rats without affecting sensitivity to delay or magnitude
    Travis M. Moschak, Suzanne H. Mitchell · 2014 · Behavioural Brain Research
83. TESTS OF BEHAVIORAL‐ECONOMIC ASSESSMENTS OF RELATIVE REINFORCER EFFICACY II: ECONOMIC COMPLEMENTS
    Gregory J. Madden, John R. Smethells, Eric Edward Ewan, Steven R. Hursh · 2007 · Journal of the Experimental Analysis of Behavior
84. Appetitive motivational deficits in individuals with Parkinson's Disease
    Danielle M. Shore, Robert D. Rafal, John A. Parkinson · 2011 · Movement Disorders
85. Modafinil Augmentation for Residual Symptoms of Fatigue in Patients with a Partial Response to Antidepressants
    Jenny Y Lam, Maisha Kelly Freeman, Marshall E. Cates · 2007 · Annals of Pharmacotherapy
86. Dopamine receptor blockade and extinction differentially affect behavioral variability.
    Jacqueline H. Rick, Jon C. Horvitz, Peter D. Balsam · 2006 · Behavioral Neuroscience
87. Predictors of Response to Adjunctive Osmotic-Release Methylphenidate or Placebo in Patients With Major Depressive Disorder
    Sakina J. Rizvi, Joseph Geraci, Arun V Ravindran, Sidney H. Kennedy · 2014 · Journal of Clinical Psychopharmacology
88. Dopamine D 2 receptors and ingestive behavior: brainstem mediates inhibition of intraoral intake and accumbens mediates aversive taste behavior in male rats
    Fredrik Sederholm, Allan E. Johnson, Ulf Brodin, P. Södersten · 2002 · Psychopharmacology
89. Venlafaxine enhances the effect of bupropion on extracellular dopamine in rat frontal cortex
    Alan L. Hudson, Maggie D. Lalies, Peter H. Silverstone · 2012 · Canadian Journal of Physiology and Pharmacology
90. Haloperidol, dynamics of choice, and the parameters of the matching law
    Carlos F. Aparício · 2007 · Behavioural Processes
91. Cerebromicrocirculatory defects in animal model of depression
    Sheldon Preskorn, Thomas A. Kent, Robin K. Glotzbach, George H. Irwin, Jay V. Solnick · 1984 · Psychopharmacology
92. Amitriptyline normalizes tetrabenazine-induced changes in cerebral microcirculation
    Thomas A. Kent, Sheldon Preskorn, Robin K. Glotzbach, George H. Irwin · 1986 · Biological Psychiatry
93. Is energy a stronger indicator of mood for those with bipolar disorder compared to those without bipolar disorder?
    Sheri Lynn Johnson, Anda Gershon, Vladimir Starov · 2015 · Psychiatry Research
94. Dopamine receptor blockade and reductions in thirst produce differential effects on drinking behavior
    Jon C. Horvitz, William B. Richardson, Aaron Ettenberg · 1993 · Pharmacology Biochemistry and Behavior
95. Clinical Nonmotor Aspect of A2A Antagonist in PD Treatment
    Masahiro Nomoto, Masahiro Nagai, Noriko Nishikawa · 2014 · International review of neurobiology
96. Treating fatigue.
    Yves Lapierre, S Hum · 2007 · PubMed
97. Which Drug For Which Patient? Is There a Fluoxetine Responding Versus a Bupropion Responding Personality Profile?
    Diana Bell, W. Mark Shipman, Mario Alberto Cleves, Jill Siegelman · 2013 · Clinical Practice and Epidemiology in Mental Health
98. Insulin and Ventral Tegmental Dopamine: What’s Impaired and What’s Intact?
    John D. Salamone, Mercè Correa · 2013 · Cell Metabolism